EKF Diagnostics buys Argutus Medical

German medical devices company EKF Diagnostics Holdings has acquired the Irish medical testing business Argutus Medical for £2.18 million.

The all share deal is AIM-listed EKF’s third acquisition to date, and upon completion Argutus’ CEO, Cormac Kilty, will become the company’s chief technical officer.

Julian Baines, EKF’s CEO, comments: ‘In addition to strengthening our [intellectual property] position, Argutus gives us the opportunity to detect kidney problems substantially earlier than currently marketed products, which fits well into our strategic goals in the point of care market.’

Dublin-based Argutus produces medical diagnostic kits for detecting organ injury, with a focus on the early detection of acute kidney damage. In the year to June 2010, Argutus declared a pre-tax loss of €727,000 (£606,000) on a turnover of €1.2 million (£1 million).

EKF was founded in 1990 and develops and manufactures medical and research diagnostic equipment, focusing on diabetes and anaemia testing. The company’s first acquisition was the reverse takeover deal with AIM-listed International Brand Licensing in June this year.

Nick Britton

Nick Britton

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics

Healthcare Sector